Abstract
Background: SLC16A1-AS1 has been characterized as an oncogenic long non-coding (lncRNA) in breast cancer and bladder cancer, while its role in cervical squamous cell carcinoma (CSCC) is unknown. Methods: CSCC and non-tumor tissue samples were collected from 60 female patients, and qPCR was performed to detect the expression of SLC16A1-AS1, miR-194 and SOCS2. Luciferase reporter assay was performed to detect the interaction between SLC16A1-AS1 and miR-194. Colony formation assay was used to detect cell proliferation. Results: SLC16A1-AS1 was down-regulated in CSCC and correlated with poor survival. Overexpression of SLC16A1-AS1 could inhibit the proliferation of cervical cancer cells. In addition, SLC16A1-AS1 could sponge miR-194 and increase the expression levels of SOCS2, ultimately inhibiting the proliferation of cervical cancer cells. Conclusion: SLC16A1-AS1 was downregulated in CSCC and suppressed cell proliferation in cervical squamous cell carcinoma (CSCC) through the miR-194/SOCS2 axis.
Author supplied keywords
Cite
CITATION STYLE
Zhang, H., Jin, S., Ji, A., Ma, Y., Zhang, C., Wang, A., & Wang, R. (2021). Lncrna slc16a1-as1 suppresses cell proliferation in cervical squamous cell carcinoma (Cscc) through the mir-194/socs2 axis. Cancer Management and Research, 13, 1299–1306. https://doi.org/10.2147/CMAR.S276629
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.